Xia L, Kilb J, Wex H, Li Z, Lipyansky A, Breuil V, Stein L, Palmer J T, Dempster D W, Brömme D
Mount Sinai School of Medicine, Department of Human Genetics, New York, NY 10029, USA.
Biol Chem. 1999 Jun;380(6):679-87. doi: 10.1515/BC.1999.084.
We have localized cathepsin K in rat osteoclasts and within exposed resorption pits by immuno-fluorescence microscopy. Intracellular staining using an antibody raised against recombinant mouse cathepsin K was vesicular and uniformly distributed throughout the cell. Confocal microscopy analysis did not reveal an accumulation of cathepsin K containing vesicles opposing the ruffled border and the resorption lacuna. Exposed resorption pits exhibited a uniform distribution of cathepsin K, and no differences were observed between the edges and the centers of the pits. The immunostaining of resorption pits with anti-cathepsin K antibodies demonstrates that the protease is secreted into the sub-osteoclastic compartment. Cathepsin K-specific inhibition using peptidyl vinyl sulfones as selective cysteine protease inactivators reduced bone resorption by 80% in a dose-dependent manner at sub-micromolar concentrations. No reduction of bone resorption was observed at those low concentrations using a potent cathepsin L, S, B-specific inhibitor. That the inhibition of bone resorption can be attributed to cathepsin K-like protease inhibition was corroborated by the selective inhibition of the osteoclastic Z-Gly-Pro-Arg-MbetaNA hydrolyzing activity by the cathepsin K, L, S, B-inhibitor, but not by the cathepsin L, B, and S inhibitor. Z-Gly-Pro-Arg-MbetaNA is efficiently hydrolyzed by cathepsin K but only poorly by cathepsins L, S, and B. On the contrary, the intracellular hydrolysis of the cathepsin B-specific substrate, Z-Arg-Arg-MbetaNA, was prevented by both types of inhibitors. The identification of cathepsin K in resorption pits and the inhibition of bone resorption and intracellular cathepsin K activity by selective vinyl sulfone inhibitors indicate the critical role of the protease in osteoclastic bone resorption.
我们通过免疫荧光显微镜将组织蛋白酶K定位在大鼠破骨细胞内以及暴露的吸收陷窝中。使用针对重组小鼠组织蛋白酶K产生的抗体进行细胞内染色,结果显示为囊泡状且均匀分布于整个细胞。共聚焦显微镜分析未发现含有组织蛋白酶K的囊泡在与皱褶缘和吸收腔相对的位置聚集。暴露的吸收陷窝呈现出组织蛋白酶K的均匀分布,在陷窝边缘和中心之间未观察到差异。用抗组织蛋白酶K抗体对吸收陷窝进行免疫染色表明,该蛋白酶被分泌到破骨细胞下间隙。使用肽基乙烯砜作为选择性半胱氨酸蛋白酶灭活剂对组织蛋白酶K进行特异性抑制,在亚微摩尔浓度下以剂量依赖方式使骨吸收降低了80%。使用强效的组织蛋白酶L、S、B特异性抑制剂在这些低浓度下未观察到骨吸收减少。组织蛋白酶K、L、S、B抑制剂对破骨细胞Z-Gly-Pro-Arg-MbetaNA水解活性的选择性抑制证实了骨吸收的抑制可归因于类似组织蛋白酶K的蛋白酶抑制,而组织蛋白酶L、B和S抑制剂则无此作用。Z-Gly-Pro-Arg-MbetaNA能被组织蛋白酶K有效水解,但仅能被组织蛋白酶L、S和B低效水解。相反,两种类型的抑制剂均能阻止组织蛋白酶B特异性底物Z-Arg-Arg-MbetaNA的细胞内水解。在吸收陷窝中鉴定出组织蛋白酶K,以及选择性乙烯砜抑制剂对骨吸收和细胞内组织蛋白酶K活性的抑制,表明该蛋白酶在破骨细胞性骨吸收中起关键作用。